Whether compounded preparations deliver equivalent outcomes is a question the FDA has explicitly declined to answer, noting that compounded medications are not reviewed for safety, effectiveness, or quality as finished products
Positioning food products as a companion to GLP-1s can offer consumers a more comprehensive, holistic approach to their weight loss goals
Safety considerations and managing sensitive eye area Periorbital skin sensitivity creates unique safety considerations beyond general peptide safety profiles due to extreme thinness increasing absorption and irritation potential, proximity to eyes creating contamination risk, and higher reactivity to active ingredients compared to other facial areas
10.1056/NEJMoa2032183 Summary Keywords GLP-1RA, tumors, diabetes, FAERS, pharmacovigilance Citation Yang Z, Lv Y, Yu M, Mei M, Xiang L, Zhao S and Li R (2022) GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS
Founded in 1929, Ipsen built its commercial franchise almost entirely on two foundational peptide drugs: Somatuline (lanreotide), a long-acting somatostatin analogue for gastroenteropancreatic neuroendocrine tumours and acromegaly
Linebarger: I studied at UT Austin, and then I went to medical school in Australia, which was an amazing experience because its a public health care system, so you really just learn medicine for medicine and not necessarily for medical legal issues or anything like that